Selective gene silencing of rat ATP-binding cassette G2 transporter in an in vitro blood-brain barrier model by short interfering RNA

Journal of Neurochemistry

Volumn 93, Issue 1, 2005, Pages 63-71

  Hori, Satoko ^a,b   Ohtsuki, Sumio ^a,b   Ichinowatari, Masashi ^a   Yokota, Takanori ^c   Kanda, Takashi ^c   Terasaki, Tetsuya ^a,b  

^a TOHOKU UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

17 estradiol; ABC transporter; ATP binding cassette transporter G2; Blood brain barrier; In vitro blood brain barrier model; Short interfering RNA

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER C1; ABC TRANSPORTER G1; BREAST CANCER RESISTANCE PROTEIN; ESTRADIOL; MULTIDRUG RESISTANCE PROTEIN 1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; BLOOD BRAIN BARRIER; CAPILLARY ENDOTHELIUM; CELL IMMORTALIZATION; CELL LEVEL; CELL STRAIN HEK293; ENDOTHELIUM CELL; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BLOOD-BRAIN BARRIER; BLOTTING, WESTERN; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; FLOW CYTOMETRY; GENE SILENCING; HUMANS; MITOXANTRONE; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 16244415183     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2004.02994.x     Document Type: Article

References (29)

1. Allen J. D. and Schinkel A. H. (2002) Multidrug resistance and pharmacological protection mediated by the breast cancer resistance protein (BCRP/ABCG2). Mol. Cancer Ther. 1, 427-434.
2. Allen J. D., van Loevezijn A., Lakhai J. M., van der Valk M., van Tellingen O., Reid G., Schellens J. H., Koomen G. J. and Schinkel A. H. (2002) Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C. Mol. Cancer Ther. 1, 417-425.
3. Asaba H., Hosoya K., Takanaga H., Ohtsuki S., Tamura E., Takizawa T. and Terasaki T. (2000) Blood-brain barrier is involved in the efflux transport of a neuroactive steroid, dehydroepiandrosterone sulfate, via organic anion transporting polypeptide 2. J. Neurochem. 75, 1907-1916.
4. de Bruin M., Miyake K., Litman T., Robey R. and Bates S. E. (1999) Reversal of resistance by GF120918 in cell lines expressing the ABC half-transporter, MXR. Cancer Leu. 146, 117-126.
5. Clarke R., Leonessa F., Welch J. N. and Skaar T. C. (2001) Cellular and molecular pharmacology of antiestrogen action and resistance. Pharmacol Rev. 53, 25-71.
6. Cooray H. C., Blackmore C. G., Maskell L. and Barrand M. A. (2002) Localisation of breast cancer resistance protein in microvessel endothelium of human brain. Neuroreport 13, 2059-2063.
7. Ee P. L., Kamalakaran S., Tonetti D., He X., Ross D. D. and Beck W. T. (2004) Identification of a novel estrogen response element in the breast cancer resistance protein (ABCG2) gene. Cancer Res. 64, 1247-1251.
8. Elbashir S. M., Harborth J., Weber K. and Tuschl T. (2002) Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 26, 199-213.
9. Gao B., Stieger B., Noe B., Fritschy J. M. and Meier P. J. (1999) Localization of the organic anion transporting polypeptide 2 (Oatp2) in capillary endothelium and choroid plexus epithelium of rat brain. J. Histochem. Cytochem. 47, 1255-1264.
10. Hannon G. J. (2002) RNA interference. Nature 418, 244-251.
11. Hori S., Ohtsuki S., Tachikawa M., Kimura N., Kondo T., Watanabe M., Nakashima E. and Terasaki T. (2004) Functional expression of rat ABCG2 on the luminal side of brain capillaries and its enhancement by astrocyte-derived soluble factor(s). J. Neurochem. 90, 526-536.
12. Hosoya K., Takashima T., Tetsuka K. et al. (2000a) mRNA expression and transport characterization of conditionally immortalized rat brain capillary endothelial cell lines; a new in vitro BBB model for drug targeting. J. Drug Target. 8, 357-370.
13. Hosoya K., Tetsuka K., Nagase K. et al. (2000b) Conditionally immortalized brain capillary endothelial cell lines established from a transgenic mouse harboring temperature-sensitive simian virus 40 large T-antigen gene. AAPS Pharmsci. 2, article 27. doi: 10.128/ ps020327 Available: http://www.aapspharmsci.org
14. Hosoya K., Ohtsuki S. and Terasaki T. (2002) Recent advances in the brain-to-blood efflux transport across the blood-brain barrier. Int. J. Pharm. 248, 15-29.
15. Hyafil F., Vergely C., Du Vignaud P. and Grand-Perret T. (1993) in vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative. Cancer Res. 53, 4595-4602.
16. Mori S., Takanaga H., Ohtsuki S., Deguchi T., Kang Y. S., Hosoya K. and Terasaki T. (2003) Rat organic anion transporter 3 (rOAT3) is responsible for brain-to-blood efflux of homovanillic acid at the abluminal membrane of brain capillary endothelial cells. J. Cereb. Blood Flow Metab. 23, 432-440.
17. Nabokina S. M., Ma T. Y. and Said H. M. (2004) Mechanism and regulation of folate uptake by the human pancreatic epithelial MIA PaCa-2 cells. Am. J. Physiol. Cell Physiol. 287, C142-C148.
18. Rabindran S. K., Ross D. D., Doyle L. A., Yang W. and Greenberger L. M. (2000) Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein. Cancer Res. 60, 47-50.
19. Reynolds A., Leake D., Boese Q., Scaringe S., Marshall W. S. and Khvorova A. (2004) Rational siRNA design for RNA interference. Nat. Biotechnol. 22, 326-330.
20. Said H. M., Balamurugan K., Subramanian V. S. and Marchant J. S. (2004) Expression and functional contribution of hTHTR-2 in thiamine absorption in human intestine. Am. J. Physiol. Gastrointest. Liver Physiol. 286, G491-G498.
21. Stirone C., Duckles S. P. and Krause D. N. (2003) Multiple forms of estrogen receptor-alpha in cerebral blood vessels: regulation by estrogen. Am. J. Physiol. Endocrinol Metab. 284, E184-E192.
22. Suzuki M., Suzuki H., Sugimoto Y. and Sugiyama Y. (2003) ABCG2 transports sulfated conjugates of steroids and xenobiotics. J. Biol. Chem. 278, 22 644-22 649.
23. Terasaki T. and Hosoya K. (1999) The blood-brain barrier efflux transporters as a detoxifying system for the brain. Adv. Drug Deliv. Rev. 36, 195-209.
24. Terasaki T., Ohtsuki S., Hori S., Takanaga H., Nakashima E. and Hosoya K. (2003) New approaches to in vitro models of blood-brain barrier drug transport. Drug Discov. Today 8, 944-954.
25. Virgintino D., Robertson D., Errede M., Benagiano V., Girolamo F., Matorano E., Roncali L. and Bertossi M. (2002) Expression of P-glycoprotein in human cerebral cortex microvessels. J. Histochem. Cytochem. 50, 1671-1676.
26. Wu H., Hait W. N. and Yang J. M. (2003) Small interfering RNA-induced suppression of MDR1 (P-glycoprotein) restores sensitivity to multidrug-resistant cancer cells. Cancer Res. 63, 1515-1519.
27. Yoshinari K., Miyagishi M. and Taira K. (2004) Effects on RNAi of the tight structure, sequence and position of the targeted region. Nucl Acids Res. 32, 691-699.
28. Zelcer N., Reid G., Wielinga P., Kuil A., van der Heijden I., Schuetz J. D. and Borst P. (2003) Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP)4 (ATP-binding cassette C4). Biochem. J. 371, 361-367.
29. Zhang Y., Boado R. J. and Pardridge W. M. (2003) In vivo knockdown of gene expression in brain cancer with intravenous RNAi in adult rats. J. Gene Med. 5, 1039-1045.